Related Experiment Video
Updated: Jun 27, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway
1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21231; New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103.
Abstract:
The efficient and regulated response to cellular stress is coordinated by a genetic regulatory network in which a given transcription factor controls the expression of diverse target genes depending on the cell type and/or nature of the stimuli. The tumor suppressor p53 is thought to preferentially regulate the balance between cell survival and death. The interferon regulatory factor 5 (IRF-5), known to be involved in the innate immune response to pathogens, is also a critical regulator of DNA damage-induced apoptosis. Here, we provide direct evidence that IRF-5 promotes apoptosis upon signaling through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors (DR). We report that IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death that is further enhanced by type I interferons. Cells deficient of IRF-5 gave a significantly diminished response to these agents. IRF-5 is involved in DR signaling upstream of caspase 8, in part because of an IRF-5-dependent increase in caspase 8 activation. We provide evidence that TRAIL induces a signaling cascade that leads to the phosphorylation and nuclear localization of IRF-5, resulting in transactivation of key DR signaling components. The results presented here identify IRF-5 as a new mediator of DR signaling and provides molecular insight into the mechanism of TRAIL-induced IRF-5 signaling.
Insights
Interferon regulatory factor 5 (IRF-5) promotes tumor cell death by sensitizing them to TRAIL-induced apoptosis. This newly identified mediator enhances cell death signaling, particularly when combined with type I interferons.
Area of Science:
- Molecular Biology
- Cellular Biology
- Immunology
Background:
- Cellular stress responses are regulated by genetic networks.
- Interferon regulatory factor 5 (IRF-5) is involved in innate immunity and DNA damage-induced apoptosis.
- Tumor suppressor p53 influences cell survival and death balance.
Purpose of the Study:
- To investigate the role of IRF-5 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor (DR) signaling.
- To elucidate the mechanism by which IRF-5 mediates apoptosis.
Main Methods:
- Investigated IRF-5's role in TRAIL-induced apoptosis in tumor cells.
- Assessed the impact of type I interferons on TRAIL-induced apoptosis in IRF-5 deficient cells.
- Analyzed IRF-5's involvement in signaling pathways upstream of caspase 8 activation.
- Examined TRAIL-induced phosphorylation and nuclear localization of IRF-5.
Main Results:
- IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death.
- Type I interferons enhance TRAIL-induced cell death in an IRF-5-dependent manner.
- Cells lacking IRF-5 show a diminished response to TRAIL and interferons.
- IRF-5 acts upstream of caspase 8, increasing its activation.
- TRAIL signaling leads to IRF-5 phosphorylation and nuclear translocation, activating DR signaling components.
Conclusions:
- IRF-5 is a novel mediator of death receptor signaling.
- IRF-5 plays a critical role in promoting apoptosis via the TRAIL pathway.
- This study provides molecular insights into TRAIL-induced IRF-5 signaling in cancer cells.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Regulation of the Unfolded Protein Response
Apoptosis
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

